Partial duplication/triplication of the short arm of chromosome 5 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:262725
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Partial duplication or triplication of the short arm of chromosome 5 (5p) syndrome (Orphanet code 262725) is a rare chromosomal anomaly in which a segment of the short arm of chromosome 5 is present in extra copies — either duplicated (trisomy for that region) or triplicated (tetrasomy). This condition is also referred to as partial trisomy 5p or partial tetrasomy 5p, depending on the extent of the extra genetic material. The clinical presentation is variable and depends on the size and precise location of the duplicated or triplicated segment, but commonly reported features include intellectual disability, developmental delay, craniofacial dysmorphism (such as macrocephaly, frontal bossing, hypertelorism, a broad or flat nasal bridge, and low-set ears), and growth abnormalities. Some patients may also present with congenital heart defects, seizures, and musculoskeletal anomalies. The condition can arise de novo or be inherited from a parent carrying a balanced chromosomal rearrangement such as a translocation or inversion. When a parent carries a balanced rearrangement, there is a recurrent risk for future pregnancies. Diagnosis is typically made through karyotyping, fluorescence in situ hybridization (FISH), or chromosomal microarray analysis, which can precisely define the breakpoints and extent of the duplicated or triplicated region. Genotype-phenotype correlations remain challenging because of the variability in segment size and gene content involved. There is currently no curative treatment for partial duplication or triplication of 5p. Management is supportive and multidisciplinary, focusing on early intervention programs for developmental delay, speech and occupational therapy, management of seizures if present, cardiac evaluation and treatment for congenital heart defects, and regular monitoring of growth and development. Genetic counseling is recommended for affected families to assess recurrence risk and guide reproductive planning.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Partial duplication/triplication of the short arm of chromosome 5 syndrome.

View clinical trials →

No actively recruiting trials found for Partial duplication/triplication of the short arm of chromosome 5 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Partial duplication/triplication of the short arm of chromosome 5 syndrome community →

No specialists are currently listed for Partial duplication/triplication of the short arm of chromosome 5 syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Partial duplication/triplication of the short arm of chromosome 5 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Partial duplication/triplication of the short arm of chromosome 5 syndromeForum →

No community posts yet. Be the first to share your experience with Partial duplication/triplication of the short arm of chromosome 5 syndrome.

Start the conversation →

Latest news about Partial duplication/triplication of the short arm of chromosome 5 syndrome

No recent news articles for Partial duplication/triplication of the short arm of chromosome 5 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Partial duplication/triplication of the short arm of chromosome 5 syndrome

What is Partial duplication/triplication of the short arm of chromosome 5 syndrome?

Partial duplication or triplication of the short arm of chromosome 5 (5p) syndrome (Orphanet code 262725) is a rare chromosomal anomaly in which a segment of the short arm of chromosome 5 is present in extra copies — either duplicated (trisomy for that region) or triplicated (tetrasomy). This condition is also referred to as partial trisomy 5p or partial tetrasomy 5p, depending on the extent of the extra genetic material. The clinical presentation is variable and depends on the size and precise location of the duplicated or triplicated segment, but commonly reported features include intellectu

At what age does Partial duplication/triplication of the short arm of chromosome 5 syndrome typically begin?

Typical onset of Partial duplication/triplication of the short arm of chromosome 5 syndrome is neonatal. Age of onset can vary across affected individuals.